Signet Healthcare Partners, a New York-based private equity firm that focuses on investing in life sciences companies, closed its third investment fund at approximately $129m.
Commitments derived from returning investors and from new industry investors and family offices.
Signet will invest this fund primarily in US and European commercial-stage companies producing generic and specialty pharmaceuticals, biopharmaceuticals, medical devices and other related technology, diagnostics, and research-based companies supporting this industry.
Over a four-year period, the vehicle will make individual investments ranging from $6m to $15m serving as lead or co-lead investor.
The team includes James C. Gale, founding partner of Signet, and managing partners Joyce Erony, Al Hansen, Martin Zeiger, Todd Sone and Samuel Altman.